BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34928263)

  • 1. Comparison of p53, HSP90, E-cadherin and HPV in oral lichen planus and oral squamous cell carcinoma.
    Bar JK; Cierpikowski P; Lis-Nawara A; Duc P; Hałoń A; Radwan-Oczko M
    Acta Otorhinolaryngol Ital; 2021 Dec; 41(6):514-522. PubMed ID: 34928263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of human papillomavirus in oral leukoplakia,oral lichen planus and oral squamous cell carcinoma].
    Cao J; Jin JQ; Deng DJ; Liu HW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):84-8. PubMed ID: 26885914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-1 expression in oral lichen planus, dysplastic lesions and squamous cell carcinoma.
    Jaafari-Ashkavandi Z; Aslani E
    Pathol Res Pract; 2017 Jul; 213(7):809-814. PubMed ID: 28554768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary level of microRNA-146a and microRNA-155 biomarkers in patients with oral lichen planus versus oral squamous cell carcinoma.
    Mehdipour M; Shahidi M; Anbari F; Mirzaei H; Jafari S; Kholghi A; Lotfi E; Manifar S; Mashhadiabbas F
    BMC Oral Health; 2023 Jun; 23(1):433. PubMed ID: 37386382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral lichen planus shows higher expressions of tumor suppressor gene products of p53 and p21 compared to oral mucositis. An immunohistochemical study.
    Safadi RA; Al Jaber SZ; Hammad HM; Hamasha AA
    Arch Oral Biol; 2010 Jun; 55(6):454-61. PubMed ID: 20427035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
    Sun L; Feng J; Ma L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of biomarker expression in oral lichen planus and oral lichenoid lesions.
    Radwan-Oczko M; Lis-Nawara A; Hałoń A; Bar J
    Adv Clin Exp Med; 2022 Dec; 31(12):1327-1334. PubMed ID: 36047896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overestimated risk of transformation in oral lichen planus.
    Cai X; Zhang J; Zhang H; Li T
    Oral Oncol; 2022 Oct; 133():106025. PubMed ID: 35858493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cathepsin-B and caveolin-1 gene expressions in oral lichen planus and oral squamous cell carcinoma.
    Pakfetrat A; Delavarian Z; Mohtasham N; Mohajer Tehran F; Samiee N
    Mol Biol Rep; 2022 Apr; 49(4):2945-2951. PubMed ID: 35138525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus.
    Xu Z; Shen Z; Shi L; Sun H; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Oct; 17(5):408-11. PubMed ID: 23707659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma.
    Ma L; Wang H; Yao H; Zhu L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Aug; 17(4):327-30. PubMed ID: 23639414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67.
    Acay RR; Felizzola CR; de Araújo N; de Sousa SO
    Oral Oncol; 2006 May; 42(5):475-80. PubMed ID: 16364678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA content, Cyclooxygenase-2 expression and loss of E-cadherin expression do not predict risk of malignant transformation in oral lichen planus.
    Neppelberg E; Johannessen AC
    Eur Arch Otorhinolaryngol; 2007 Oct; 264(10):1223-30. PubMed ID: 17530268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma.
    Leyva-Huerta ER; Ledesma-Montes C; Rojo-Botello RE; Vega-Memije E
    Med Oral Patol Oral Cir Bucal; 2012 Sep; 17(5):e745-50. PubMed ID: 22549684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination of oral squamous cell carcinoma from oral lichen planus by salivary metabolomics.
    Ishikawa S; Sugimoto M; Edamatsu K; Sugano A; Kitabatake K; Iino M
    Oral Dis; 2020 Jan; 26(1):35-42. PubMed ID: 31602722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genomic and proteomic landscape in oral lichen planus versus oral squamous cell carcinoma: a scoping review.
    Xie F; Meves A; Lehman JS
    Int J Dermatol; 2022 Oct; 61(10):1227-1236. PubMed ID: 35575880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression.
    Yang Q; Sun H; Wang X; Yu X; Zhang J; Guo B; Hexige S
    J Cell Mol Med; 2020 Jan; 24(2):1179-1188. PubMed ID: 31793175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of topical corticosteroids on malignant transformation of oral lichen planus.
    Bindakhil M; Akintoye S; Corby P; Stoopler ET; Greenberg MS; Shanti R; Tanaka TI; Sollecito TP
    J Oral Pathol Med; 2022 Feb; 51(2):188-193. PubMed ID: 34748663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
    Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
    Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential.
    Lončar-Brzak B; Klobučar M; Veliki-Dalić I; Sabol I; Kraljević Pavelić S; Krušlin B; Mravak-Stipetić M
    Clin Oral Investig; 2018 Mar; 22(2):1071-1082. PubMed ID: 28779221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.